![David Eveleth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Eveleth
Amministratore Delegato presso Trefoil Therapeutics, Inc.
Posizioni attive di David Eveleth
Società | Posizione | Inizio | Fine |
---|---|---|---|
Trefoil Therapeutics, Inc.
![]() Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - | - |
Amministratore Delegato | - | - | |
Direttore Finanziario/CFO | - | - |
Storia della carriera di David Eveleth
Statistiche
Distribuzione geografica
Stati Uniti | 2 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Director of Finance/CFO | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Trefoil Therapeutics, Inc.
![]() Trefoil Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trefoil Therapeutics, Inc. operates as a biotechnology company. The firm develops applications for the eFGFs include regenerative therapies that may address a broad range of ischemic disease, including coronary heart disease, diabetic ulcers, and peripheral artery disease. The company was founded by Ralph Bradshaw, Ken Thomas and Michael Blaber in 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- David Eveleth
- Esperienza